Increasing barrier method use among oral contraceptive users at risk of STDs: What approach is best?

Sexually Transmitted Diseases

Volumn 25, Issue 3, 1998, Pages 139-143

  Steiner, Markus J ^a   Glover, Lucinda H ^a   Bou Saada, Ingrid ^b   Piedrahita, Carla ^c  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b IL   (United States)

^c Brazos Valley Community Action   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONOXINOL 9; ORAL CONTRACEPTIVE AGENT; SPERMICIDAL AGENT;

ADULT; ARTICLE; CONDOM; CONTROLLED STUDY; FEMALE; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE;

AMERICAS; BARRIER METHODS; BEHAVIOR; CONDOM; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE METHODS; CONTRACEPTIVE USAGE--WOMEN; DEVELOPED COUNTRIES; DISEASES; ECONOMIC FACTORS; FAMILY PLANNING; INFECTIONS; LOW INCOME POPULATION--WOMEN; NONOXYNOL-9; NORTH AMERICA; NORTHERN AMERICA; ORAL CONTRACEPTIVES; REPRODUCTIVE TRACT INFECTIONS; RESEARCH REPORT; RISK REDUCTION BEHAVIOR--WOMEN; SEX BEHAVIOR--WOMEN; SEXUALLY TRANSMITTED DISEASES--PREVENTION AND CONTROL; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SOCIOECONOMIC STATUS; SPERMICIDAL CONTRACEPTIVE AGENTS; TEXAS; UNITED STATES;

ADULT; CONDOMS; CONTRACEPTIVES, ORAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; SEXUALLY TRANSMITTED DISEASES;

EID: 0031932484     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199803000-00006     Document Type: Article

References (21)

1. Cates W Jr, Stone KM. Family planning, sexually transmitted diseases and contraceptive choice: A literature update - part I. Fam Plann Perspect 1992; 24:75-84.
2. Hatcher RA, Trussell J, Stewart F, et al. Contraceptive Technology, 16th rev. ed. New York: Irvington Publishers, 1994.
3. Santelli JS, Davis M, Celentano DD, Crump AD, Burwell LG. Combined use of condoms with other contraceptive methods among inner-city Baltimore women. Fam Plann Perspect 1995; 27:74-78.
4. Weisman CS, Plichta S, Nathanson CA, et al. Consistency of condom use for disease prevention among adolescent users of oral contraceptives. Fam Plann Perspect 1991; 23:71-74.
5. Niruthisard S, Roddy RE, Chutivongse. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet 1992; 339:1371-1375.
6. Louv WC, Austin H, Alexander WJ, Stagno S, Cheeks J. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. J Infect Dis 1988; 158:518-523.
7. New York State Department of Health AIDS Institute. Women and HIV Prevention: Methods of Personal Protection, a Policy Statement. Focus on AIDS in New York State, July 1992.
8. Cleary J, Winters S. Female condom: Efficacy, acceptability and relationship to the women's hierarchy of risk reduction. Division of HIV Prevention. New York State Department of Health AIDS Institute, January 1994.
9. Stein ZA. Editorial: The double bind in science policy and the protection of women from HIV infection. Am J Pub Health 1992; 82:1471-1472.
10. Rosenberg MJ, Gollub EL. Commentary: Methods women can use that may prevent sexually transmitted disease, including HIV. Am J Pub Health. 1992; 1473-1478.
11. Cates W Jr, Stewart FH, Trussell J. Commentary: The quest for women's prophylactic methods-hopes vs science. Am J Pub Health 1992; 82:1479-1482.
12. Catania J, Coates TJ, Stall R, et al. Prevalence of AIDS-related risk factors and condom use in the United States. Science 1992; 258:1101-1106.
13. Cates W Jr. A risk-assessment tool for integrated reproductive health services. Int Fam Plann Perspect 1997; 23:36-38.
14. Thomas T, Choudhri S, Kariuki C, Moses S. Identifying cervical infection among pregnant women in Nairobi, Kenya: Limitations of risk assessment and symptom-based approaches. Genitourin Med 1996; 72:334-338.
15. Senn S. Testing for baseline balance in clinical trials. Stat Med 1994; 13:1715-1726.
16. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. New York: Oxford University Press, 1994.
17. Chen PL, Wong E, Dominik R, Steiner MJ. A transitional model for assessing barrier methods compliance adjusting for nonrandom loss to follow-up, presented at the Joint Statistical Meeting of the American Statistical Association, Anaheim, CA, 1997.
18. U.S. Preventive Services Task Force. Guide to clinical preventive services, 2nd ed. Baltimore: Williams & Wilkins, 1996:862.
19. Farr G, Castro LAA, Disantostefano R, Claassen E, Olguin F. Use of a spermicide and impact of prophylactic condom use among sex workers in Santa Fe de Bogota, Colombia. Sex Transm Dis 1996; 23:206-212.
20. Gollub EL, Stein Z, El-Sadr W. Short-term acceptability of the female condom among staff and patients at a New York City hospital. Fam Plann Perspect 1995; 27:155-158.
21. Novello AC, Peterson HB, Arrowsmith-Lowe JT, From the Surgeon General, US Public Service. Condom use for prevention of sexual transmission of HIV infection. JAMA 1993; 269:2840.